🇺🇸 FDA
Pipeline program

TRF (Tocotrienol-rich-fraction)

123314MP4F

Unknown other completed

Quick answer

TRF (Tocotrienol-rich-fraction) for End Stage Renal Disease is a Unknown program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
End Stage Renal Disease
Phase
Unknown
Modality
other
Status
completed

Clinical trials